Both in Pharmaceuticals
Faeth Therapeutics vs CytomX Therapeutics
Over the past year FTH returned −50.1% and CTMX returned −28.9%; their daily moves had a correlation of 0.62.
FTH −50.1% CTMX −28.9%Growth of $1, one year, split-adjusted
| Metric | FTH | CTMX |
|---|---|---|
| Price | $18.69 | $2.34 |
| Market cap | $483.0M | $509.9M |
| Today | −0.32% | +2.18% |
| 1 month | −33.9% | −11.0% |
| 6 months | — | −44.0% |
| Year to date | — | −45.1% |
| 1 year | — | −28.2% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 27.9× |
| Net cash | $186.4M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 67.3% |
| Short % of float | 16.6% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).